The latest ESPAUR report (2024–2025) paints a sobering picture of AMR in England. While prescribing practices have improved in some areas, the resistant infections are increasing, and new threats like Candidozyma auris are emerging.
Continue readingamr
Addressing health inequalities using IPC
Guest blogger Kerry Holden (bio below) has written this blog in preparation for next Wednesday’s Journal Club (register here) writes…
Health inequalities are sadly deeply embedded in society and unfortunately growing, leading to unequal access to services and poor care experiences. These disparities contribute to earlier deaths, reduced healthy life expectancy, intergenerational trauma, and substantial economic costs. However, many of these health inequalities are preventable.
Continue readingWater-free patient care: a narrative review of the literature
In preparation for today’s Journal Club in partnership with the Healthcare Infection Society around water hygiene (details and registration here), I’ve reviewed this article in the Journal of Hospital Infection.
Why I choose this article?
Waterborne healthcare associated infections (and the prevention of), have always been an area of interest for me. Papers and evidence identifying the significance of the risk (particularly in the intensive care setting), and the challenges posed by outlets other than sinks and showers, such as toilets (read related blog here) have increased significantly.
This has resulted in novel ways of reducing the risks posed by waterborne infections being explored, including the concept of water-free or water light patient care. With that in mind I was really interested to read this article by Teresa Inkster and colleagues. What better way than a narrative review from some of the world’s leading authorities on water, to examine if there really is a benefit to implementing water-free care?
Using a defined search criterion, the narrative review identified seven papers, the majority of which focused on implementing water-free care in the intensive care unit (ICU) setting.
Key findings
- Water-free care was largely instigated in response to outbreaks by Gram-negative bacteria (GNB)
- 2 of the papers reported outbreaks of multidrug resistant Pseudomonas aeruginosa. In both papers removal or limiting use of sinks and implementing water-free alternatives resulted in the termination of outbreaks.
- 2 papers reported outbreaks in neonatal intensive care. One the studies conducted in Australia, showed that complete removal of sinks (apart for one sink for hand washing at entry and exit points) result in decreased colonisation of neonates with GNB and the unit reporting no outbreaks (traceable to water systems) for over 10 years!
- 2 quasi experimental studies both conducted in ICU settings reported benefits when implementing water-free care. One of the studies showed an overall decrease in GNB colonisation rates. The other study showed a reduction in the incidence of MDR GNB infection, with the greatest impact observed on reducing new cases of Klebsiella pneumoniae.
Limitations of the study
The studies identified in the narrative review are weakly powered. Further research should focus on higher powered studies which focus on water-free care as the sole intervention. We can also aspire to a randomised controlled trial to hopefully provide unequivocal evidence. There are also questions to be answered on the methodology we use to sample a sink (something Jon Otter and I wrote about recently). Where and how do we sample? Can we employ whole genome sequencing more effectively?
What strategies should be adopted by healthcare providers?
Terminating outbreaks and reducing colonisation of GNB are clear benefits when implementing water-free care. The authors helpfully set out challenges which need to be addressed before healthcare providers can consider the implementation of water-free strategies. These challenges include:
- ‘Water-free’ being a confusing term which can be a barrier in itself
- Risk from water and wastewater systems are not appropriately risk assessed in terms of risk to vulnerable patients
- Surveillance methods often lack sensitivity
- Standard IPC precautions are designed to be ‘catch all’ so lack effectiveness in preventing water and wastewater transmission events
Requirement for change
The article highlights the looming global antimicrobial resistance (AMR) crisis and considers the current strategy of infection control, antimicrobial stewardship and development of new antibiotics, being largely ‘oblivious’ to the built environment. The authors make an excellent point that through improved design, installation and commission/maintenance the built environment provides an excellent opportunity to tackle the AMR crisis head on. The authors go on to emphasise how the UK New Hospital Programme (NHP) provides an opportunity to develop solutions to implement optimal water-free care. I couldn’t agree more!
As part of the requirement for change the authors also highlight why the move to water-free care has been relatively slow. These factors include lack of awareness and recognition of risks, low sensitivity of surveillance, concerns of risk to patient safety when removing clinical hand wash basins and an increase in skin related conditions (associated with increased alcohol-based sanitisers).
What this means for IPC?
Clearly the evidence surrounding the reduction in risk and transmission of healthcare associated infections when adopting water-free care is gathering traction. There is work to do to overcome the challenges, but also opportunities via the NHP. The authors call for empowerment of clinical staff, followed by ownership to support the successful implementation of water-free care. However, this requires support and guidance from organisations such as the Department of Health (in England).
Collaboration between IPC and estates and facilities staff, as well as executive buy in and engagement with front line staff is required to reduce the risks associated with water and wastewater. Overcoming barriers to implement water-free care will rely on a change in culture and financial investment to support its successful adoption and for the benefits to be realised. Finally with the looming AMR crisis, prevention is always better than cure, especially as we are running out of options for the cure (antibiotics)!
Farewell 2024 – ESPAUR helps us to set priorities for 2025
As we bid farewell to 2024, a time for reflection, objective setting, and the odd new years resolution to break early in 2025. The latest ESPAUR report was published a few months ago, and helps us to set some priorities for 2025 and beyond. As ever, there’s a mixture of good news and bad news in the report, but mostly I’m grateful that we have sufficient data and co-ordination to give us this level of detail about the current and emerging threats related to HCAI and AMR in the UK.
Continue readingThe country lottery: where you live influences infection outcomes
I have posted before about the “postcode lottery” and it’s influence on rates of MRSA, affecting deprived postcodes (or zipcodes!) more than others. But this issue is wider than regional influence. On an international scale, your changes of a bad outcome from infectious disease varies, sometimes wildly, by where you happen to be in the world. A new article in CID on clinical outcomes from carbapenem-resistant Acinetobacter baumannii infections bears this out.
Continue readingBug in a mug?
The Christmas BMJ usually has something to do with infection or infection control. But this year it has excelled, with an article all about bacterial contamination of coffee machines! So, next time you press the magic button for a caffeine hit in the staff room, do you need to think twice? Well, not really – whilst a few possible pathogens were identified, your coffee isn’t likely to give you an antibiotic-resistant bacterium for Christmas!
Continue readingThe “top 10” scientific articles influencing our IPC practice over the past year
I had the pleasure of doing a talk at Infection Prevention 2023 in Liverpool today, running down the top 10 scientific articles influencing our IPC practice over the past year. You can download my slides here.
I had some trouble selecting just 10 papers from the past year, and felt a strong sense of my own bias and limitations when going through the selection process. I have my own research and clinical interests, I don’t read anywhere near as many papers as I’d like, and 10 papers really isn’t that many! Also, I tried to countdown the papers from 10 to 1 with some kind of hierarchy. After a couple of false starts here (including the most read, most controversial, best designed), I settled on the most influential in terms of challenging our thinking or modifying our practice.
So, here goes…
Continue readingPredicting colonisation with antibiotic-resistant bacteria at the time of hospital admission
A systematic review and meta-analysis identify 22 studies that used various methods to predict colonisation with antibiotic-resistant bacteria at the time of hospital admission. The models were chosen to focus on MRSA and CPO colonisation. The “performance” of these tools varied widely, with a sensitivity of 15–100% and specificity of 46–98.6% for MRSA, and sensitivity of 30–81.3% and specificity of 79.8–99.9% for CPO. I think my main take-away from this that simple risk tools for predicting colonisation with MRSA and CPO (which are often used to determine who to test) are pretty blunt instruments. However, the more advanced tools making use of big datasets and machine learning can take us forward in predicting the risk of MRSA and CPO colonisation at the time of admission.
Continue readingHCAI and AMR point prevalence from Ukraine
JHI have just published an interesting point prevalence HCAI and AMR study from Ukraine. Headlines are that rates of both HCAI and AMR are higher than you’d hope to see, especially with rates of resistant to carbapenems in Gram-negative bacteria and meticillin in S. aureus.
Continue readingThree key headlines from ESPAUR 2022
Great to see another fantastic annual ESPAUR report. It really is marvellous to have such a clear picture of HCAI and AMR related trends. As ever, there is some good news and some not so good news. Here three key headlines:
- Trends in bloodstream infection, antimicrobial resistance, and antimicrobial prescribing have changed during the pandemic.
- Tackling deprivation is tackling HCAI and AMR.
- We need to keep an eye on CPE